{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:33:31Z","timestamp":1761514411697,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","semthorcardiovascsurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1053\/j.semtcvs.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T23:50:24Z","timestamp":1560901824000},"page":"1125-1132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of Clinically Lymph Node-Positive Malignant Pleural Mesothelioma"],"prefix":"10.1053","volume":"32","author":[{"given":"Vivek","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney E.","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary D.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"2nd","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semtcvs.2019.06.004_bib0001","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1200\/JCO.1993.11.6.1172","article-title":"Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma","volume":"11","author":"Sugarbaker","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0002","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0003","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0003-4975(99)01038-3","article-title":"Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically","volume":"68","author":"Rusch","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0004","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0003-4975(03)00010-9","article-title":"The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma","volume":"75","author":"Schouwink","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.athoracsur.2008.04.012","article-title":"Prevalence and pattern of lymph node metastasis in malignant pleural mesothelioma","volume":"86","author":"Abdel Rahman","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0006","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jtcvs.2005.11.044","article-title":"The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma","volume":"131","author":"Edwards","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0007","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jtcvs.2008.02.069","article-title":"The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the American Joint Committee on Cancer staging system","volume":"136","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0008","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","article-title":"Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: Novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients","volume":"260","author":"Sugarbaker","year":"2014","journal-title":"Ann Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jtcvs.2006.06.044","article-title":"Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"133","author":"de Perrot","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0011","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2016.08.071","article-title":"Extended pleurectomy-decortication-based treatment for advanced stage epithelial mesothelioma yielding a median survival of nearly three years","volume":"103","author":"Friedberg","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0012","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.athoracsur.2008.01.088","article-title":"The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma","volume":"85","author":"Mineo","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0013","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: Clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0014","unstructured":"National Comprehensive Cancer Network. Malignant pleural mesothelioma. Version 2.2018. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpm.pdf. Accessed November 16, 2018"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0015","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jtho.2018.08.2036","article-title":"Current and future management of malignant mesothelioma: A consensus report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation","volume":"13","author":"Tsao","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0016","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: A powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0017","unstructured":"American Joint Committee on Cancer. Summary of Changes: Understanding the changes from the sixth to the seventh edition of the AJCC Cancer Staging Manual 2010. https:\/\/cancerstaging.org\/references-tools\/deskreferences\/Documents\/AJCCSummaryofChanges.pdf. Accessed November 19, 2018"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0018","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/j.cllc.2018.08.007","article-title":"Survival by histologic subtype of malignant pleural mesothelioma and the impact of surgical resection on overall survival","volume":"19","author":"Verma","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0019","unstructured":"National Comprehensive Cancer Network. Malignant pleural mesothelioma. Version 2.2015. https:\/\/www2.tri-kobe.org\/nccn\/guideline\/lung\/english\/mpm.pdf. Accessed November 16, 2018"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population","volume":"5","author":"Flores","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0021","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","article-title":"Malignant pleural mesothelioma: A population-based study of survival","volume":"5","author":"Milano","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0022","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jtho.2017.08.012","article-title":"National Cancer Database report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma","volume":"12","author":"Verma","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lungcan.2018.03.019","article-title":"Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Database analysis","volume":"120","author":"Verma","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0024","article-title":"Treatment of malignant pleural mesothelioma with chemotherapy preceding versus following surgical resection","author":"Verma","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0025","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","article-title":"Malignant peritoneal Mesothelioma: National practice patterns, outcomes, and predictors of survival","volume":"25","author":"Verma","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0026","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/j.cllc.2018.04.019","article-title":"Utilization of intensity-modulated radiation therapy for malignant pleural mesothelioma in the United States","volume":"19","author":"Shaaban","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2019.03.003","article-title":"Chemotherapy versus supportive care for unresected malignant pleural mesothelioma","author":"Verma","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1053\/j.semtcvs.2019.06.004_bib0028","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-019-07351-6","article-title":"Management of malignant pleural mesothelioma in the elderly population","author":"Verma","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067919301777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067919301777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:33:37Z","timestamp":1760906017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067919301777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"alternative-id":["S1043067919301777"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2019.06.004","relation":{},"ISSN":["1043-0679"],"issn-type":[{"type":"print","value":"1043-0679"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Clinically Lymph Node-Positive Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}